These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12001839)

  • 41. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
    Critchley J; Liu J; Zhao D; Wei W; Capewell S
    Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early intervention and prevention of myocardial infarction.
    Pais PS
    J Hypertens Suppl; 2006 Apr; 24(2):S25-30. PubMed ID: 16601557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Clin Pharmacol; 2009 Aug; 49(8):947-56. PubMed ID: 19602720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The challenge of risk reduction therapy for cardiovascular disease.
    Smith SC
    Am Fam Physician; 1997 Feb; 55(2):491-500. PubMed ID: 9054219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
    Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824
    [No Abstract]   [Full Text] [Related]  

  • 49. Physical inactivity as a risk factor for coronary heart disease: a WHO and International Society and Federation of Cardiology position statement.
    Bijnen FC; Caspersen CJ; Mosterd WL
    Bull World Health Organ; 1994; 72(1):1-4. PubMed ID: 8131243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary artery disease epidemic in Indians: a cause for alarm and call for action.
    Enas EA
    J Indian Med Assoc; 2000 Nov; 98(11):694-5, 697-702. PubMed ID: 11265799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Controlling coronary risk through nutrition.
    Nestel PJ
    Can J Cardiol; 1995 Oct; 11 Suppl G():9G-14G. PubMed ID: 7585300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preventive cardiology: smoking, lipids and atherosclerosis, and blood pressure.
    Schieken RM
    Curr Opin Cardiol; 1990 Feb; 5(1):58-61. PubMed ID: 10149317
    [No Abstract]   [Full Text] [Related]  

  • 53. [Preventing coronary heart disease by physical activity. How much exercise is necessary?].
    Graf C; Bjarnason-Wehrens B; Rost R
    MMW Fortschr Med; 2001 Jan; 143(4):28-30. PubMed ID: 11219278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in coronary heart disease mortality in New Zealand and Sweden. Why the difference?
    Sharpe N; Vedin A; Wilhelmsen L; Wilhelmsson C
    N Z Med J; 1985 Nov; 98(791):1002-5. PubMed ID: 3866184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary fiber and coronary artery disease.
    Chu WW; Hanson PG
    WMJ; 2000 Oct; 99(7):32-6. PubMed ID: 11089448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary artery disease in women: a silent killer.
    Shah SN; Shah V; Chandrasekran K
    J Okla State Med Assoc; 1999 Jun; 92(6):267-72. PubMed ID: 10363433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Coronary risk factors in the Mexican population].
    Zorrilla E
    Arch Inst Cardiol Mex; 1985; 55(5):405-9. PubMed ID: 2935097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perspectives on prevention and medical education for the 1990s.
    Nickens HW; Petersdorf RG
    Am J Prev Med; 1990; 6(2 Suppl):1-5. PubMed ID: 2383407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prevention of ischemic heart disease--experiences and conclusions from the Erfurt intervention study].
    Knappe J
    Z Gesamte Inn Med; 1987 Oct; 42(19):536-9. PubMed ID: 3424884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholesterol reduction to prevent CAD. What do the data show?
    Sorrentino MJ
    Postgrad Med; 2000 Dec; 108(7):40-2, 45-6, 49-52. PubMed ID: 11126142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.